Market Closed -
Bombay S.E.
06:00:50 2024-05-03 am EDT
|
5-day change
|
1st Jan Change
|
1,655
INR
|
+0.46%
|
|
+2.44%
|
+25.11%
|
Fiscal Period: Maart |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
334,438
|
267,133
|
463,185
|
339,061
|
294,760
|
754,380
|
-
|
-
|
Enterprise Value (EV)
1 |
379,293
|
285,450
|
476,416
|
366,521
|
324,269
|
779,280
|
763,898
|
744,729
|
P/E ratio
|
55.3
x
|
-99.1
x
|
38.2
x
|
-22.2
x
|
68.8
x
|
38.3
x
|
32.7
x
|
26.9
x
|
Yield
|
0.68%
|
1.02%
|
0.64%
|
0.54%
|
0.62%
|
0.43%
|
0.52%
|
0.61%
|
Capitalization / Revenue
|
2
x
|
1.74
x
|
3.05
x
|
2.07
x
|
1.77
x
|
3.8
x
|
3.47
x
|
3.15
x
|
EV / Revenue
|
2.27
x
|
1.86
x
|
3.14
x
|
2.23
x
|
1.95
x
|
3.92
x
|
3.51
x
|
3.1
x
|
EV / EBITDA
|
13.2
x
|
12.1
x
|
18.6
x
|
16.9
x
|
18.8
x
|
21.4
x
|
18.2
x
|
15.2
x
|
EV / FCF
|
55.7
x
|
35.9
x
|
41.6
x
|
-68.2
x
|
81.6
x
|
59.7
x
|
36.3
x
|
29.7
x
|
FCF Yield
|
1.79%
|
2.79%
|
2.4%
|
-1.47%
|
1.23%
|
1.68%
|
2.76%
|
3.37%
|
Price to Book
|
2.44
x
|
2.13
x
|
3.36
x
|
2.79
x
|
2.36
x
|
5.34
x
|
4.69
x
|
4.1
x
|
Nbr of stocks (in thousands)
|
452,494
|
452,998
|
453,680
|
454,475
|
454,981
|
455,750
|
-
|
-
|
Reference price
2 |
739.1
|
589.7
|
1,021
|
746.0
|
647.8
|
1,655
|
1,655
|
1,655
|
Announcement Date
|
5/15/19
|
5/28/20
|
5/12/21
|
5/18/22
|
5/9/23
|
-
|
-
|
-
|
Fiscal Period: Maart |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
167,182
|
153,748
|
151,630
|
164,055
|
166,417
|
198,661
|
217,377
|
239,858
|
EBITDA
1 |
28,822
|
23,548
|
25,669
|
21,656
|
17,206
|
36,412
|
42,063
|
48,925
|
EBIT
1 |
25,252
|
13,846
|
16,795
|
5,069
|
8,399
|
26,419
|
31,343
|
37,424
|
Operating Margin
|
15.1%
|
9.01%
|
11.08%
|
3.09%
|
5.05%
|
13.3%
|
14.42%
|
15.6%
|
Earnings before Tax (EBT)
1 |
15,172
|
7,572
|
16,764
|
-13,726
|
7,165
|
25,289
|
30,167
|
36,937
|
Net income
1 |
6,066
|
-2,694
|
12,165
|
-15,280
|
4,301
|
19,847
|
23,228
|
28,287
|
Net margin
|
3.63%
|
-1.75%
|
8.02%
|
-9.31%
|
2.58%
|
9.99%
|
10.69%
|
11.79%
|
EPS
2 |
13.36
|
-5.950
|
26.72
|
-33.65
|
9.410
|
43.26
|
50.55
|
61.56
|
Free Cash Flow
1 |
6,806
|
7,957
|
11,441
|
-5,378
|
3,974
|
13,058
|
21,057
|
25,106
|
FCF margin
|
4.07%
|
5.18%
|
7.55%
|
-3.28%
|
2.39%
|
6.57%
|
9.69%
|
10.47%
|
FCF Conversion (EBITDA)
|
23.61%
|
33.79%
|
44.57%
|
-
|
23.09%
|
35.86%
|
50.06%
|
51.32%
|
FCF Conversion (Net income)
|
112.21%
|
-
|
94.05%
|
-
|
92.39%
|
65.8%
|
90.65%
|
88.76%
|
Dividend per Share
2 |
5.000
|
6.000
|
6.500
|
4.000
|
4.000
|
7.151
|
8.549
|
10.15
|
Announcement Date
|
5/15/19
|
5/28/20
|
5/12/21
|
5/18/22
|
5/9/23
|
-
|
-
|
-
|
Fiscal Period: March |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
40,174
|
37,831
|
42,702
|
40,913
|
41,609
|
38,830
|
37,438
|
41,455
|
43,222
|
44,301
|
48,141
|
48,189
|
48,810
|
50,871
|
52,043
|
EBITDA
1 |
7,787
|
7,076
|
9,647
|
5,557
|
3,698
|
2,666
|
1,639
|
4,342
|
5,160
|
6,040
|
8,565
|
8,076
|
8,705
|
9,950
|
-
|
EBIT
1 |
5,344
|
4,918
|
7,560
|
-3,636
|
1,664
|
-605.4
|
-288.9
|
2,307
|
2,956
|
3,401
|
6,218
|
5,627
|
5,621
|
7,472
|
7,286
|
Operating Margin
|
13.3%
|
13%
|
17.7%
|
-8.89%
|
4%
|
-1.56%
|
-0.77%
|
5.57%
|
6.84%
|
7.68%
|
12.92%
|
11.68%
|
11.52%
|
14.69%
|
14%
|
Earnings before Tax (EBT)
1 |
5,248
|
5,184
|
7,505
|
-22,048
|
1,671
|
-851.6
|
22.7
|
2,096
|
2,461
|
2,585
|
5,588
|
5,462
|
5,626
|
6,435
|
-
|
Net income
1 |
4,382
|
4,604
|
5,425
|
-20,980
|
5,455
|
-5,180
|
-890.8
|
1,297
|
1,535
|
2,360
|
4,523
|
3,969
|
4,436
|
5,229
|
-
|
Net margin
|
10.91%
|
12.17%
|
12.7%
|
-51.28%
|
13.11%
|
-13.34%
|
-2.38%
|
3.13%
|
3.55%
|
5.33%
|
9.39%
|
8.24%
|
9.09%
|
10.28%
|
-
|
EPS
2 |
9.700
|
10.11
|
11.91
|
-46.22
|
11.98
|
-11.40
|
-1.960
|
2.850
|
3.360
|
5.160
|
9.900
|
8.267
|
9.445
|
10.42
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
1/28/21
|
5/12/21
|
8/10/21
|
10/27/21
|
2/3/22
|
5/18/22
|
8/3/22
|
11/9/22
|
2/9/23
|
5/9/23
|
8/3/23
|
-
|
-
|
-
|
-
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
44,855
|
18,317
|
13,231
|
27,460
|
29,509
|
24,899
|
9,518
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
9,651
|
Leverage (Debt/EBITDA)
|
1.556
x
|
0.7779
x
|
0.5155
x
|
1.268
x
|
1.715
x
|
0.6838
x
|
0.2263
x
|
-
|
Free Cash Flow
1 |
6,806
|
7,957
|
11,441
|
-5,378
|
3,974
|
13,058
|
21,057
|
25,106
|
ROE (net income / shareholders' equity)
|
4.44%
|
2.68%
|
9.24%
|
-11.8%
|
3.49%
|
14.3%
|
15.2%
|
16.1%
|
ROA (Net income/ Total Assets)
|
2.24%
|
1.33%
|
5.01%
|
-6.73%
|
1.92%
|
8.38%
|
9.42%
|
10.9%
|
Assets
1 |
271,278
|
-202,214
|
242,971
|
227,157
|
223,883
|
236,905
|
246,612
|
259,211
|
Book Value Per Share
2 |
303.0
|
277.0
|
304.0
|
267.0
|
274.0
|
310.0
|
353.0
|
403.0
|
Cash Flow per Share
2 |
36.70
|
32.40
|
40.00
|
8.080
|
41.50
|
51.20
|
63.20
|
72.30
|
Capex
1 |
9,854
|
6,731
|
6,776
|
9,051
|
14,996
|
8,195
|
8,224
|
8,351
|
Capex / Sales
|
5.89%
|
4.38%
|
4.47%
|
5.52%
|
9.01%
|
4.12%
|
3.78%
|
3.48%
|
Announcement Date
|
5/15/19
|
5/28/20
|
5/12/21
|
5/18/22
|
5/9/23
|
-
|
-
|
-
|
Last Close Price
1,655
INR Average target price
1,516
INR Spread / Average Target -8.41% Consensus |
1st Jan change
|
Capi.
|
---|
| +25.11% | 9.05B | | +26.08% | 662B | | +21.85% | 546B | | -4.77% | 359B | | +16.97% | 323B | | +5.69% | 290B | | +13.68% | 234B | | +3.65% | 198B | | -11.12% | 194B | | -3.40% | 157B |
Other Pharmaceuticals
|